Wells Fargo & Company Nektar Therapeutics Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Nektar Therapeutics stock. As of the latest transaction made, Wells Fargo & Company holds 108,975 shares of NKTR stock, worth $96,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares
108,975
Previous 86,153 26.49%
Holding current value
$96,987
Previous $111,000 9.01%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$0.9 - $1.45 $20,539 - $33,091
22,822 Added 26.49%
108,975 $101,000
Q3 2024

Nov 13, 2024
BUY
$1.11 - $1.48 $4,077 - $5,436
3,673 Added 4.45%
86,153 $111,000
Q2 2024

Aug 13, 2024
BUY
$0.9 - $1.83 $69,611 - $141,543
77,346 Added 1506.54%
82,480 $102,000
Q1 2024

May 10, 2024
BUY
$0.49 - $0.96 $12 - $24
26 Added 0.51%
5,134 $4,000
Q4 2023

Feb 09, 2024
SELL
$0.42 - $0.57 $28 - $39
-69 Reduced 1.33%
5,108 $2,000
Q3 2023

Nov 13, 2023
SELL
$0.51 - $1.05 $1,786 - $3,678
-3,503 Reduced 40.36%
5,177 $3,000
Q2 2023

Aug 15, 2023
SELL
$0.53 - $1.03 $31,617 - $61,445
-59,656 Reduced 87.3%
8,680 $5,000
Q1 2023

May 12, 2023
BUY
$0.64 - $3.15 $34,997 - $172,254
54,684 Added 400.56%
68,336 $47,000
Q4 2022

Feb 13, 2023
SELL
$2.03 - $4.28 $16,782 - $35,382
-8,267 Reduced 37.72%
13,652 $30,000
Q3 2022

Nov 14, 2022
SELL
$3.04 - $5.14 $726 - $1,228
-239 Reduced 1.08%
21,919 $70,000
Q2 2022

Aug 12, 2022
SELL
$3.17 - $6.17 $276,439 - $538,054
-87,205 Reduced 79.74%
22,158 $84,000
Q1 2022

May 16, 2022
SELL
$4.16 - $13.72 $23,075 - $76,104
-5,547 Reduced 4.83%
109,363 $590,000
Q4 2021

Feb 14, 2022
SELL
$10.83 - $18.41 $517,533 - $879,758
-47,787 Reduced 29.37%
114,910 $1.55 Million
Q3 2021

Nov 15, 2021
SELL
$13.07 - $18.84 $275,959 - $397,787
-21,114 Reduced 11.49%
162,697 $2.92 Million
Q2 2021

Aug 16, 2021
SELL
$16.52 - $20.4 $127,815 - $157,834
-7,737 Reduced 4.04%
183,811 $3.16 Million
Q1 2021

May 13, 2021
SELL
$16.56 - $25.46 $1.03 Million - $1.58 Million
-61,967 Reduced 24.44%
191,548 $3.83 Million
Q4 2020

Feb 09, 2021
BUY
$15.77 - $19.03 $1.28 Million - $1.54 Million
81,011 Added 46.96%
253,515 $4.31 Million
Q3 2020

Nov 05, 2020
SELL
$16.59 - $24.79 $1.49 Million - $2.23 Million
-89,888 Reduced 34.26%
172,504 $2.86 Million
Q2 2020

Aug 13, 2020
SELL
$16.86 - $23.44 $88,194 - $122,614
-5,231 Reduced 1.95%
262,392 $6.08 Million
Q1 2020

May 14, 2020
BUY
$14.47 - $27.96 $3.87 Million - $7.48 Million
267,623 New
267,623 $4.78 Million

Others Institutions Holding NKTR

# of Institutions
145
Shares Held
142M
Call Options Held
32.6K
Put Options Held
14.1K
View Full List

About NEKTAR THERAPEUTICS

NKTR Quotes by TradingView
  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $167M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email